Caso clínico: Se describe una mujer de 16 años con epilepsia severa que desarrolló una hemianopsia homónima izquierda después de tomar topiramato 125 mg durante 12 semanas y una mujer epiléptica de 24 años que presentó una maculopatía bilateral después de tomar 150 mg de topiramato durante 8 semanas. Discusión: Se identifican dos reacciones oculares adversas al topiramato. Ambas precisan retirar el tratamiento, aunque la maculopatía por topiramato es irreversible.
Case reports: We describe 2 patients who developed ocular side effects during treatment with topiramate. One was a 16-year-old woman with generalized seizures who developed a homonymous hemianopia after using topiramate 125 mg per day for 12 weeks, and the other was a 24-year-old epileptic female who developed a bilateral maculopathy after using topiramate 150 mg per day for 8 weeks. Discussion: We identified two severe ocular adverse reactions from topiramate. Both reactions necessitated discontinuing the treatment, but the topiramate-associated maculopathy was irreversible.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados